The transcriptomics market is witnessing remarkable growth, driven by an increasing understanding of gene expression and its implications for health and disease. Currently valued at USD 7.73 billion, the market is projected to reach approximately USD 16.03 billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 6.85%. This growth is emblematic of a broader shift in the...